Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group

BACKGROUND: Data on the safety and efficacy of immune checkpoint inhibitors (ICI) in patients with concurrent autoimmune diseases (AID) are limited. METHODS: We performed a retrospective multicenter review of medical records of patients with cancer and underlying AID who received ICI. The primary en...

Descripción completa

Detalles Bibliográficos
Autores principales: Fountzilas, Elena, Lampaki, Sofia, Koliou, Georgia-Angeliki, Koumarianou, Anna, Levva, Sofia, Vagionas, Anastasios, Christopoulou, Athina, Laloysis, Athanasios, Psyrri, Amanda, Binas, Ioannis, Mountzios, Giannis, Kentepozidis, Nikolaos, Kotsakis, Athanassios, Saloustros, Emmanouil, Boutis, Anastasios, Nikolaidi, Adamantia, Fountzilas, George, Georgoulias, Vassilis, Chrysanthidis, Miltiadis, Kotteas, Elias, Vo, Henry, Tsiatas, Marinos, Res, Eleni, Linardou, Helena, Daoussis, Dimitrios, Bompolaki, Iliada, Andreadou, Anna, Papaxoinis, George, Spyratos, Dionisios, Gogas, Helen, Syrigos, Konstantinos N., Bafaloukos, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783878/
https://www.ncbi.nlm.nih.gov/pubmed/34164709
http://dx.doi.org/10.1007/s00262-021-02985-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783878/
https://www.ncbi.nlm.nih.gov/pubmed/34164709
http://dx.doi.org/10.1007/s00262-021-02985-6

Ejemplares similares